Erythropoietin (Epo) and Venofer Trial After Autologous Hematopoietic Stem Cell Transplantation (HSCT)

NCT00557817 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

125

Enrollment

OTHER

Sponsor class

Conditions

Hematological Malignancies

Interventions

DRUG: Darbepoetin alpha (Aranesp)
DRUG: Iron saccharate (Venofer)

Sponsor

University of Liege

Collaborators

[object Object]
[object Object]
[object Object]